Bidisha Bandyopadhyay

An Immunohistochemistry Proved Extensive Inflammatory Myofibroblastic Tumour of Lung: Being Treated with Crizotinib

Satadru Biswas, Bidisha Bandyopadhyay, Hambir Chowdhury, Kuntal Ray, Debanti Banerjee, Ritam Joarder, Souvik Paul, Debapriya Mondal, Sukanta Chakraborty & Chhaya Roy · Journal of Cancer and Tumor International · 2018

Inflammatory Myofibroblastic Tumour (IMT) is a rare entity which constitutes 0.04–1.2% of all lung tumours. Though IMT was first described as an ‘Interesting Benign Lung Tumour’, recurrence, the discovery of cytogenetic aberrations, a clonal population of cells and oncogenic prot...

Open access Research Article 10.9734/JCTI/2018/39255

A Large Solid Pseudopapillary Tumour of the Body and Tail of Pancreas: A Rare Entity Treated with Combined Modality

Satadru Biswas, Bidisha Bandyopadhyay, Hambir Chowdhury, Sukanta Chakraborty, Abhishek Basu & Subir Gangopadhyay · International Journal of Medical and Pharmaceutical Case Reports · 2017

Solid Pseudopapillary Tumour (SPPT) of the pancreas are rare tumours, accounting for only 1-2% of all pancreatic neoplasms. Increased rate of detection of this neoplasm in the last three decades is probably due to the increased awareness and the increased provision of imaging. Th...

Open access Research Article 10.9734/IJMPCR/2017/37962